Signal active
Contact Information
Social
Primary Organization
2015
11-50
Biotechnology, Health Care, Biopharma, Therapeutics
Bio
Dr. Chengbin Wu is the founder and Chief Executive Officer of EpimAb Biotherapeutics. Until end of April 2016 he was Chief Scientific Officer and President of R&D at Shanghai CP Guojian Pharmaceutical Co., a leading China-based biopharmaceutical company focusing on developing therapeutic antibodies to treat various diseases. Previously he was the Senior VP Biologics at Shanghai ChemPartner, where he established comprehensive biologics R&D capabilities.
Before that he was a Volwiler Associate Fellow at Abbott laboratories, USA. Dr. Wu has extensive experience in engineering and development of therapeutic monoclonal antibodies. He is also the primary inventor of the DVD-Ig technology, a new bi-specific antibody platform for developing next generation biologics therapies. Dr. Wu received his Ph.D. degree from the University of Georgia in the US, and postdoctoral training at Harvard Medical School.
Location
Shanghai, Shanghai, China, Asia
Jobs history
0
N/A
Educations
1
Biochemistry and Moleculer Biology
Profile Resume
Chengbin Wu is the CEO at EpimAb Biotherapeutics, based in Asia. With a background in Biotechnology, Chengbin Wu has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.